[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456045":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":20,"locations":30,"responsibleParty":46,"collaborators":11,"id":50,"slug":11,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":56,"sex":57,"minAge":58,"maxAge":11,"enrollmentInfo":59,"targetDuration":11,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":11,"overallStatus":33,"whyStopped":11,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Central Hospital, Nancy, France","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All subjects will have an MRI examination","EXPERIMENTAL",null,[13],"Device: MRI examination",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DEVICE","MRI examination","All subjects (healthy and pathological subjects) will have an MRI examination with a component of the MRI system under development.",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},"Damien MANDRY, MD, PhD","CONTACT","+33383154202","d.mandry@chru-nancy.fr",{"name":27,"role":23,"phone":28,"phoneExt":11,"email":29},"Gabriela HOSSU, PhD","+33383155096","g.hossu@chru-nancy.fr",[31],{"facility":32,"status":33,"city":34,"state":11,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"CHRU de Nancy","RECRUITING","Nancy","54000","France","FR",{"type":39,"coordinates":40},"Point",[41,42],6.18496,48.68439,{"lat":42,"lon":41},[45],{"name":22,"role":23,"phone":24,"phoneExt":11,"email":25},{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Pedro TEIXEIRA-GONDIM, MD","Principal Investigator","100456045",false,"NCT05218460","Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam on Voluntary Subjects","EDEN","Inclusion Criteria for all subjects :\n\n* to be over 18 year-old,\n* to be enrolled in a social security plan,\n* to have underwent a pre-inclusion medical examination,\n* to give a written consent.\n\nInclusion Criteria for volunteers with pathology :\n\n\\- person with a pathology characterized by a functional and \u002F or morphological alteration that may have an impact on the data collected (images, physiological signals, ...).\n\nExclusion Criteria for all subjects :\n\n* any contraindication to MR examination (active medical device, ferromagnetic foreign body, pregnancy, morbid obesity, claustrophobia, … ),\n* subject under a measure of legal protection,\n* Person who refuses to be informed by a doctor in th event of a fortuitus discovery of an abnormality on the MRI examination requiring additionnal examinations or specific treatment.",true,"ALL","18 Years",{"count":60,"type":61},720,"ESTIMATED","INTERVENTIONAL",[64],"NA","The EDEN study will make it possible to evaluate one or more development phases (from design to validation through optimization) of a method or a technique on voluntary subjects, in normal or pathological condition.",[67,68],"Healthy","Pathology","2026-06-16",{"date":71,"type":72},"2026-06-17","ACTUAL",{"date":74,"type":72},"2022-05-23",{"date":76,"type":61},"2027-05-23",{"name":5,"class":6},1]